Parkinson’s Disease Treatment Market Report

Global Parkinson’s Disease Treatment Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Mar 18, 2021
  • PAGES：151
  • REPORT CODE：GMM629580
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Parkinson’s Disease Treatment is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Parkinson’s Disease Treatment market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Parkinson’s Disease Treatment industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Parkinson’s Disease Treatment Market Segmentations:

    By Players:

    • Teva (Israel)

    • Strides (India)

    • Lundbeck (Denmark)

    • Wockhardt (India)

    • 1 A Pharma (India)

    • Acadia (US)

    • Dr Reddy’s (India)

    • Boehringer Ingelheim (Germany)

    • Sun Pharma (India)

    • Intas (India)

    • US WorldMeds (US)

    • Valeant Pharmaceuticals (Canada)

    • UCB (Belgium)

    • Impax Laboratories (US)

    • Zydus Cadila (India)

    • Merck (US)

    • Upsher-Smith (US)

    • AbbVie (US)

    • Novartis AG (Switzerland)

    • Cipla (India)

    • GSK (UK)

    By Types:

    • Oral

    • Transdermal

    • Subcutaneous

    • Intestinal Infusion

    By End-User:

    • Hospital Pharmacy

    • Retail Pharmacy

    • Online Pharmacy

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Parkinson’s Disease Treatment Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Parkinson’s Disease Treatment Market Size and Growth Rate of Oral from 2014 to 2026

      • 1.3.2 Global Parkinson’s Disease Treatment Market Size and Growth Rate of Transdermal from 2014 to 2026

      • 1.3.3 Global Parkinson’s Disease Treatment Market Size and Growth Rate of Subcutaneous from 2014 to 2026

      • 1.3.4 Global Parkinson’s Disease Treatment Market Size and Growth Rate of Intestinal Infusion from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Parkinson’s Disease Treatment Market Size and Growth Rate of Hospital Pharmacy from 2014 to 2026

      • 1.4.2 Global Parkinson’s Disease Treatment Market Size and Growth Rate of Retail Pharmacy from 2014 to 2026

      • 1.4.3 Global Parkinson’s Disease Treatment Market Size and Growth Rate of Online Pharmacy from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Parkinson’s Disease Treatment Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Parkinson’s Disease Treatment Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Parkinson’s Disease Treatment by Major Types

      • 3.4.1 Parkinson’s Disease Treatment Market Size and Growth Rate of Oral

      • 3.4.2 Parkinson’s Disease Treatment Market Size and Growth Rate of Transdermal

      • 3.4.3 Parkinson’s Disease Treatment Market Size and Growth Rate of Subcutaneous

      • 3.4.4 Parkinson’s Disease Treatment Market Size and Growth Rate of Intestinal Infusion

    4 Segmentation of Parkinson’s Disease Treatment Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Parkinson’s Disease Treatment by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Parkinson’s Disease Treatment in Hospital Pharmacy

      • 4.4.2 Market Size and Growth Rate of Parkinson’s Disease Treatment in Retail Pharmacy

      • 4.4.3 Market Size and Growth Rate of Parkinson’s Disease Treatment in Online Pharmacy

    5 Market Analysis by Major Regions

    • 5.1 Global Parkinson’s Disease Treatment Production Analysis by Major Regions

    • 5.2 Global Parkinson’s Disease Treatment Consumption Analysis by Major Regions

    • 5.3 Global Parkinson’s Disease Treatment Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Parkinson’s Disease Treatment Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Parkinson’s Disease Treatment Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Parkinson’s Disease Treatment Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Parkinson’s Disease Treatment Production, Import, Consumption and Export Analysis

    6 Product Commodity of Parkinson’s Disease Treatment Market in Major Countries

    • 6.1 Top 5 Export Countries in Parkinson’s Disease Treatment market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Parkinson’s Disease Treatment market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Parkinson’s Disease Treatment market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Parkinson’s Disease Treatment market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Parkinson’s Disease Treatment market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Parkinson’s Disease Treatment market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Parkinson’s Disease Treatment Landscape Analysis

    • 7.1 North America Parkinson’s Disease Treatment Landscape Analysis by Major Types

    • 7.2 North America Parkinson’s Disease Treatment Landscape Analysis by Major End-Users

    • 7.3 North America Parkinson’s Disease Treatment Landscape Analysis by Major Countries

      • 7.3.1 United States Parkinson’s Disease Treatment Market Volume and Growth Rate

      • 7.3.2 Canada Parkinson’s Disease Treatment Market Volume and Growth Rate

      • 7.3.3 Mexico Parkinson’s Disease Treatment Market Volume and Growth Rate

    8 Europe Parkinson’s Disease Treatment Landscape Analysis

    • 8.1 Europe Parkinson’s Disease Treatment Landscape Analysis by Major Types

    • 8.2 Europe Parkinson’s Disease Treatment Landscape Analysis by Major End-Users

    • 8.3 Europe Parkinson’s Disease Treatment Landscape Analysis by Major Countries

      • 8.3.1 Germany Parkinson’s Disease Treatment Market Volume and Growth Rate

      • 8.3.2 UK Parkinson’s Disease Treatment Market Volume and Growth Rate

      • 8.3.3 France Parkinson’s Disease Treatment Market Volume and Growth Rate

      • 8.3.4 Italy Parkinson’s Disease Treatment Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Parkinson’s Disease Treatment Market Volume and Growth Rate

      • 8.3.6 Spain Parkinson’s Disease Treatment Market Volume and Growth Rate

      • 8.3.7 Belgium Parkinson’s Disease Treatment Market Volume and Growth Rate

      • 8.3.8 Poland Parkinson’s Disease Treatment Market Volume and Growth Rate

      • 8.3.9 Russia Parkinson’s Disease Treatment Market Volume and Growth Rate

      • 8.3.10 Turkey Parkinson’s Disease Treatment Market Volume and Growth Rate

    9 Asia Pacific Parkinson’s Disease Treatment Landscape Analysis

    • 9.1 Asia Pacific Parkinson’s Disease Treatment Landscape Analysis by Major Types

    • 9.2 Asia Pacific Parkinson’s Disease Treatment Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Parkinson’s Disease Treatment Landscape Analysis by Major Countries

      • 9.3.1 China Parkinson’s Disease Treatment Market Volume and Growth Rate

      • 9.3.2 Japan Parkinson’s Disease Treatment Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Parkinson’s Disease Treatment Market Volume and Growth Rate

      • 9.3.4 India Parkinson’s Disease Treatment Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Parkinson’s Disease Treatment Market Volume and Growth Rate

      • 9.3.6 South Korea Parkinson’s Disease Treatment Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Parkinson’s Disease Treatment Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Parkinson’s Disease Treatment Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Parkinson’s Disease Treatment Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Parkinson’s Disease Treatment Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Parkinson’s Disease Treatment Market Volume and Growth Rate

      • 10.3.2 Brazil Parkinson’s Disease Treatment Market Volume and Growth Rate

      • 10.3.3 Nigeria Parkinson’s Disease Treatment Market Volume and Growth Rate

      • 10.3.4 South Africa Parkinson’s Disease Treatment Market Volume and Growth Rate 

      • 10.3.5 Argentina Parkinson’s Disease Treatment Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Teva (Israel)

      • 11.1.1 Teva (Israel) Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Strides (India)

      • 11.2.1 Strides (India) Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Lundbeck (Denmark)

      • 11.3.1 Lundbeck (Denmark) Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Wockhardt (India)

      • 11.4.1 Wockhardt (India) Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 1 A Pharma (India)

      • 11.5.1 1 A Pharma (India) Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Acadia (US)

      • 11.6.1 Acadia (US) Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Dr Reddy’s (India)

      • 11.7.1 Dr Reddy’s (India) Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Boehringer Ingelheim (Germany)

      • 11.8.1 Boehringer Ingelheim (Germany) Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Sun Pharma (India)

      • 11.9.1 Sun Pharma (India) Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Intas (India)

      • 11.10.1 Intas (India) Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 US WorldMeds (US)

      • 11.11.1 US WorldMeds (US) Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Valeant Pharmaceuticals (Canada)

      • 11.12.1 Valeant Pharmaceuticals (Canada) Company Profile and Recent Development

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 UCB (Belgium)

      • 11.13.1 UCB (Belgium) Company Profile and Recent Development

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 Impax Laboratories (US)

      • 11.14.1 Impax Laboratories (US) Company Profile and Recent Development

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 Zydus Cadila (India)

      • 11.15.1 Zydus Cadila (India) Company Profile and Recent Development

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    • 11.16 Merck (US)

      • 11.16.1 Merck (US) Company Profile and Recent Development

      • 11.16.2 Market Performance

      • 11.16.3 Product and Service Introduction

    • 11.17 Upsher-Smith (US)

      • 11.17.1 Upsher-Smith (US) Company Profile and Recent Development

      • 11.17.2 Market Performance

      • 11.17.3 Product and Service Introduction

    • 11.18 AbbVie (US)

      • 11.18.1 AbbVie (US) Company Profile and Recent Development

      • 11.18.2 Market Performance

      • 11.18.3 Product and Service Introduction

    • 11.19 Novartis AG (Switzerland)

      • 11.19.1 Novartis AG (Switzerland) Company Profile and Recent Development

      • 11.19.2 Market Performance

      • 11.19.3 Product and Service Introduction

    • 11.20 Cipla (India)

      • 11.20.1 Cipla (India) Company Profile and Recent Development

      • 11.20.2 Market Performance

      • 11.20.3 Product and Service Introduction

    • 11.21 GSK (UK)

      • 11.21.1 GSK (UK) Company Profile and Recent Development

      • 11.21.2 Market Performance

      • 11.21.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 79 Figures and 138 Tables)

    • Figure Product Picture

    • Figure Parkinson’s Disease Treatment Market Size and Growth Rate of Oral from 2014 to 2026

    • Figure Parkinson’s Disease Treatment Market Size and Growth Rate of Transdermal from 2014 to 2026

    • Figure Parkinson’s Disease Treatment Market Size and Growth Rate of Subcutaneous from 2014 to 2026

    • Figure Parkinson’s Disease Treatment Market Size and Growth Rate of Intestinal Infusion from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Parkinson’s Disease Treatment Market Size and Growth Rate of Hospital Pharmacy from 2014 to 2026

    • Figure Global Parkinson’s Disease Treatment Market Size and Growth Rate of Retail Pharmacy from 2014 to 2026

    • Figure Global Parkinson’s Disease Treatment Market Size and Growth Rate of Online Pharmacy from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Parkinson’s Disease Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Parkinson’s Disease Treatment Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Parkinson’s Disease Treatment

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Parkinson’s Disease Treatment by Different Types from 2014 to 2026

    • Table Consumption Share of Parkinson’s Disease Treatment by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Oral

    • Figure Market Size and Growth Rate of Transdermal

    • Figure Market Size and Growth Rate of Subcutaneous

    • Figure Market Size and Growth Rate of Intestinal Infusion

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Parkinson’s Disease Treatment by Different End-Users from 2014 to 2026

    • Table Consumption Share of Parkinson’s Disease Treatment by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital Pharmacy

    • Figure Market Size and Growth Rate of Retail Pharmacy

    • Figure Market Size and Growth Rate of Online Pharmacy

    • Table Global Parkinson’s Disease Treatment Production by Major Regions

    • Table Global Parkinson’s Disease Treatment Production Share by Major Regions

    • Figure Global Parkinson’s Disease Treatment Production Share by Major Regions in 2014

    • Figure Global Parkinson’s Disease Treatment Production Share by Major Regions in 2018

    • Figure Global Parkinson’s Disease Treatment Production Share by Major Regions in 2026

    • Table Global Parkinson’s Disease Treatment Consumption by Major Regions

    • Table Global Parkinson’s Disease Treatment Consumption Share by Major Regions

    • Figure Global Parkinson’s Disease Treatment Consumption Share by Major Regions in 2014

    • Figure Global Parkinson’s Disease Treatment Consumption Share by Major Regions in 2018

    • Figure Global Parkinson’s Disease Treatment Consumption Share by Major Regions in 2026

    • Table North America Parkinson’s Disease Treatment Production, Import, Consumption and Export Analysis

    • Table Europe Parkinson’s Disease Treatment Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Parkinson’s Disease Treatment Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Parkinson’s Disease Treatment Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Parkinson’s Disease Treatment market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Parkinson’s Disease Treatment market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Parkinson’s Disease Treatment market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Parkinson’s Disease Treatment market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Parkinson’s Disease Treatment Consumption by Types from 2014 to 2026

    • Table North America Parkinson’s Disease Treatment Consumption Share by Types from 2014 to 2026

    • Figure North America Parkinson’s Disease Treatment Consumption Share by Types in 2014

    • Figure North America Parkinson’s Disease Treatment Consumption Share by Types in 2018

    • Figure North America Parkinson’s Disease Treatment Consumption Share by Types in 2026

    • Table North America Parkinson’s Disease Treatment Consumption by End-Users from 2014 to 2026

    • Table North America Parkinson’s Disease Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure North America Parkinson’s Disease Treatment Consumption Share by End-Users in 2014

    • Figure North America Parkinson’s Disease Treatment Consumption Share by End-Users in 2018

    • Figure North America Parkinson’s Disease Treatment Consumption Share by End-Users in 2026

    • Table North America Parkinson’s Disease Treatment Consumption by Major Countries from 2014 to 2026

    • Table North America Parkinson’s Disease Treatment Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Parkinson’s Disease Treatment Consumption Share by Major Countries in 2014

    • Figure North America Parkinson’s Disease Treatment Consumption Share by Major Countries in 2018

    • Figure North America Parkinson’s Disease Treatment Consumption Share by Major Countries in 2026

    • Figure United States Parkinson’s Disease Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Parkinson’s Disease Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Parkinson’s Disease Treatment Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Parkinson’s Disease Treatment Consumption by Types from 2014 to 2026

    • Table Europe Parkinson’s Disease Treatment Consumption Share by Types from 2014 to 2026

    • Figure Europe Parkinson’s Disease Treatment Consumption Share by Types in 2014

    • Figure Europe Parkinson’s Disease Treatment Consumption Share by Types in 2018

    • Figure Europe Parkinson’s Disease Treatment Consumption Share by Types in 2026

    • Table Europe Parkinson’s Disease Treatment Consumption by End-Users from 2014 to 2026

    • Table Europe Parkinson’s Disease Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Parkinson’s Disease Treatment Consumption Share by End-Users in 2014

    • Figure Europe Parkinson’s Disease Treatment Consumption Share by End-Users in 2018

    • Figure Europe Parkinson’s Disease Treatment Consumption Share by End-Users in 2026

    • Table Europe Parkinson’s Disease Treatment Consumption by Major Countries from 2014 to 2026

    • Table Europe Parkinson’s Disease Treatment Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Parkinson’s Disease Treatment Consumption Share by Major Countries in 2014

    • Figure Europe Parkinson’s Disease Treatment Consumption Share by Major Countries in 2018

    • Figure Europe Parkinson’s Disease Treatment Consumption Share by Major Countries in 2026

    • Figure Germany Parkinson’s Disease Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Parkinson’s Disease Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure France Parkinson’s Disease Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Parkinson’s Disease Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Parkinson’s Disease Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Parkinson’s Disease Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Parkinson’s Disease Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Parkinson’s Disease Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Parkinson’s Disease Treatment Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Parkinson’s Disease Treatment Consumption by Types from 2014 to 2026

    • Table Asia Pacific Parkinson’s Disease Treatment Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Parkinson’s Disease Treatment Consumption Share by Types in 2014

    • Figure Asia Pacific Parkinson’s Disease Treatment Consumption Share by Types in 2018

    • Figure Asia Pacific Parkinson’s Disease Treatment Consumption Share by Types in 2026

    • Table Asia Pacific Parkinson’s Disease Treatment Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Parkinson’s Disease Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Parkinson’s Disease Treatment Consumption Share by End-Users in 2014

    • Figure Asia Pacific Parkinson’s Disease Treatment Consumption Share by End-Users in 2018

    • Figure Asia Pacific Parkinson’s Disease Treatment Consumption Share by End-Users in 2026

    • Table Asia Pacific Parkinson’s Disease Treatment Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Parkinson’s Disease Treatment Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Parkinson’s Disease Treatment Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Parkinson’s Disease Treatment Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Parkinson’s Disease Treatment Consumption Share by Major Countries in 2026

    • Figure China Parkinson’s Disease Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Parkinson’s Disease Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandParkinson’s Disease Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure India Parkinson’s Disease Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Parkinson’s Disease Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Parkinson’s Disease Treatment Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Parkinson’s Disease Treatment Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Parkinson’s Disease Treatment Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Parkinson’s Disease Treatment Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Parkinson’s Disease Treatment Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Parkinson’s Disease Treatment Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Parkinson’s Disease Treatment Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Parkinson’s Disease Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Parkinson’s Disease Treatment Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Parkinson’s Disease Treatment Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Parkinson’s Disease Treatment Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Parkinson’s Disease Treatment Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Parkinson’s Disease Treatment Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Parkinson’s Disease Treatment Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Parkinson’s Disease Treatment Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Parkinson’s Disease Treatment Consumption Share by Major Countries in 2026

    • Figure GCC Countries Parkinson’s Disease Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Parkinson’s Disease Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Parkinson’s Disease Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Parkinson’s Disease Treatment Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Parkinson’s Disease Treatment Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Teva (Israel)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva (Israel)

    • Figure Sales and Growth Rate Analysis of Teva (Israel)

    • Figure Revenue and Market Share Analysis of Teva (Israel)

    • Table Product and Service Introduction of Teva (Israel)

    • Table Company Profile and Development Status of Strides (India)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Strides (India)

    • Figure Sales and Growth Rate Analysis of Strides (India)

    • Figure Revenue and Market Share Analysis of Strides (India)

    • Table Product and Service Introduction of Strides (India)

    • Table Company Profile and Development Status of Lundbeck (Denmark)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lundbeck (Denmark)

    • Figure Sales and Growth Rate Analysis of Lundbeck (Denmark)

    • Figure Revenue and Market Share Analysis of Lundbeck (Denmark)

    • Table Product and Service Introduction of Lundbeck (Denmark)

    • Table Company Profile and Development Status of Wockhardt (India)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Wockhardt (India)

    • Figure Sales and Growth Rate Analysis of Wockhardt (India)

    • Figure Revenue and Market Share Analysis of Wockhardt (India)

    • Table Product and Service Introduction of Wockhardt (India)

    • Table Company Profile and Development Status of 1 A Pharma (India)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of 1 A Pharma (India)

    • Figure Sales and Growth Rate Analysis of 1 A Pharma (India)

    • Figure Revenue and Market Share Analysis of 1 A Pharma (India)

    • Table Product and Service Introduction of 1 A Pharma (India)

    • Table Company Profile and Development Status of Acadia (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Acadia (US)

    • Figure Sales and Growth Rate Analysis of Acadia (US)

    • Figure Revenue and Market Share Analysis of Acadia (US)

    • Table Product and Service Introduction of Acadia (US)

    • Table Company Profile and Development Status of Dr Reddy’s (India)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr Reddy’s (India)

    • Figure Sales and Growth Rate Analysis of Dr Reddy’s (India)

    • Figure Revenue and Market Share Analysis of Dr Reddy’s (India)

    • Table Product and Service Introduction of Dr Reddy’s (India)

    • Table Company Profile and Development Status of Boehringer Ingelheim (Germany)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim (Germany)

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim (Germany)

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim (Germany)

    • Table Product and Service Introduction of Boehringer Ingelheim (Germany)

    • Table Company Profile and Development Status of Sun Pharma (India)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharma (India)

    • Figure Sales and Growth Rate Analysis of Sun Pharma (India)

    • Figure Revenue and Market Share Analysis of Sun Pharma (India)

    • Table Product and Service Introduction of Sun Pharma (India)

    • Table Company Profile and Development Status of Intas (India)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Intas (India)

    • Figure Sales and Growth Rate Analysis of Intas (India)

    • Figure Revenue and Market Share Analysis of Intas (India)

    • Table Product and Service Introduction of Intas (India)

    • Table Company Profile and Development Status of US WorldMeds (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of US WorldMeds (US)

    • Figure Sales and Growth Rate Analysis of US WorldMeds (US)

    • Figure Revenue and Market Share Analysis of US WorldMeds (US)

    • Table Product and Service Introduction of US WorldMeds (US)

    • Table Company Profile and Development Status of Valeant Pharmaceuticals (Canada)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant Pharmaceuticals (Canada)

    • Figure Sales and Growth Rate Analysis of Valeant Pharmaceuticals (Canada)

    • Figure Revenue and Market Share Analysis of Valeant Pharmaceuticals (Canada)

    • Table Product and Service Introduction of Valeant Pharmaceuticals (Canada)

    • Table Company Profile and Development Status of UCB (Belgium)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of UCB (Belgium)

    • Figure Sales and Growth Rate Analysis of UCB (Belgium)

    • Figure Revenue and Market Share Analysis of UCB (Belgium)

    • Table Product and Service Introduction of UCB (Belgium)

    • Table Company Profile and Development Status of Impax Laboratories (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Impax Laboratories (US)

    • Figure Sales and Growth Rate Analysis of Impax Laboratories (US)

    • Figure Revenue and Market Share Analysis of Impax Laboratories (US)

    • Table Product and Service Introduction of Impax Laboratories (US)

    • Table Company Profile and Development Status of Zydus Cadila (India)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zydus Cadila (India)

    • Figure Sales and Growth Rate Analysis of Zydus Cadila (India)

    • Figure Revenue and Market Share Analysis of Zydus Cadila (India)

    • Table Product and Service Introduction of Zydus Cadila (India)

    • Table Company Profile and Development Status of Merck (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck (US)

    • Figure Sales and Growth Rate Analysis of Merck (US)

    • Figure Revenue and Market Share Analysis of Merck (US)

    • Table Product and Service Introduction of Merck (US)

    • Table Company Profile and Development Status of Upsher-Smith (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Upsher-Smith (US)

    • Figure Sales and Growth Rate Analysis of Upsher-Smith (US)

    • Figure Revenue and Market Share Analysis of Upsher-Smith (US)

    • Table Product and Service Introduction of Upsher-Smith (US)

    • Table Company Profile and Development Status of AbbVie (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie (US)

    • Figure Sales and Growth Rate Analysis of AbbVie (US)

    • Figure Revenue and Market Share Analysis of AbbVie (US)

    • Table Product and Service Introduction of AbbVie (US)

    • Table Company Profile and Development Status of Novartis AG (Switzerland)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG (Switzerland)

    • Figure Sales and Growth Rate Analysis of Novartis AG (Switzerland)

    • Figure Revenue and Market Share Analysis of Novartis AG (Switzerland)

    • Table Product and Service Introduction of Novartis AG (Switzerland)

    • Table Company Profile and Development Status of Cipla (India)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cipla (India)

    • Figure Sales and Growth Rate Analysis of Cipla (India)

    • Figure Revenue and Market Share Analysis of Cipla (India)

    • Table Product and Service Introduction of Cipla (India)

    • Table Company Profile and Development Status of GSK (UK)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK (UK)

    • Figure Sales and Growth Rate Analysis of GSK (UK)

    • Figure Revenue and Market Share Analysis of GSK (UK)

    • Table Product and Service Introduction of GSK (UK)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US